Cargando…
Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa
Biosimilars are biological products that efficiently replicate the function of the originator products. They have changed the prognosis of millions of patients with many serious conditions. The main engine beyond their development is to bring competition into the marketplace, accordingly further the...
Autores principales: | Batran, Radwa Ahmed, Elmoshneb, Mai, Hussein, Ahmed Salah, Hussien, Omar M, Adel, Fady, Elgarhy, Reham, Morsi, Mosaad I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550021/ https://www.ncbi.nlm.nih.gov/pubmed/36225324 http://dx.doi.org/10.2147/BTT.S376959 |
Ejemplares similares
-
Review and results of a survey about biosimilars prescription and challenges in the Middle East and North Africa region
por: Farhat, Fadi, et al.
Publicado: (2016) -
Review of Leishmaniasis in the Middle East and North Africa
por: Tabbabi, Ahmed
Publicado: (2019) -
Cardiovascular Risk Factor Burden in Africa and the Middle East: The Africa Middle East Cardiovascular Epidemiological (ACE) Study
por: Alsheikh-Ali, Alawi A., et al.
Publicado: (2014) -
Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa
por: Almaaytah, Ammar
Publicado: (2020) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East
por: Kandeil, Ahmed, et al.
Publicado: (2019)